FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Gelber Jeremy
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/7/2020 

3. Issuer Name and Ticker or Trading Symbol

American Renal Associates Holdings, Inc. [ARA]
(Last)        (First)        (Middle)

AMERICAN RENAL ASSOCIATES HOLDINGS, INC., 500 CUMMINGS CENTER, SUITE 6550
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

BEVERLY, MA 01915      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:

Remarks:
Dr. Gelber, a Senior Managing Director of Centerbridge Partners, L.P. or one of its affiliates ("Centerbridge") is a member of the board of directors of American Renal Associates Holdings, Inc. (the "Issuer"). Certain affiliates of Centerbridge previously filed a separate Form 3 reporting securities of the Issuer that they may be deemed to beneficially own. Dr. Gelber disclaims beneficial ownership of any securities of the Issuer that may be deemed to be beneficially owned by affiliates of Centerbridge.

Exhibit 24 - Power of Attorney
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Gelber Jeremy
AMERICAN RENAL ASSOCIATES HOLDINGS, INC.
500 CUMMINGS CENTER, SUITE 6550
BEVERLY, MA 01915
X



Signatures
/s/ Victoria A. Labriola, by power of attorney5/15/2020
**Signature of Reporting PersonDate

American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more American Renal Associates Charts.
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more American Renal Associates Charts.